Corrigendum: Concurrent use of oral anticoagulants and sulfonylureas in individuals with type 2 diabetes and risk of hypoglycemia: a UK population-based cohort study

類似資料

• Corrigendum: Concurrent use of oral anticoagulants and sulfonylureas in individuals with type 2 diabetes and risk of hypoglycemia: a UK population-based cohort study
  著者:: Hassan Alwafi, 等
  出版事項: (2024-01-01)
• An Overview of the Pharmacogenetics of Sulfonylurea in Type 2 Diabetes Mellitus
  著者:: Bayan Aljabali, 等
  出版事項: (2024-07-01)
• Pharmacoeconomic aspects of the use of sulfonylurea drugs in type 2 diabetes mellitus
  著者:: Alla Vsevolodovna Rudakova
  出版事項: (2011-09-01)
• OCTREOTIDE FOR TREATMENT RECURRENT HYPOGLYCEMIA INDUCED BY SULFONYLUREA: A CASE REPORT AND LITERATURE REVIEW
  著者:: Yuddy Imowanto, 等
  出版事項: (2024-09-01)
• Alogliptin – the new member of DPP-4 inhibitors class
  著者:: Nina Aleksandrovna Petunina, 等
  出版事項: (2014-12-01)